 |
 |
 |
| |
High Virologic Suppression and few Virologic Failures with Long-Acting Cabotegravir + Rilpivirine in Treatment Experienced Virologically Suppressed Individuals from COMBINE-2 cohort in Europe
|
| |
| |
IAS 2025, the 13th IAS conference on HIV Science>
Anton Pozniak,1










|
| |
|
 |
 |
|
|